Webinar: Why Patient-Specific Insulin Dosing Matters. Register Now
Clinical Evidence
Glucose Management Protocol Development: A Successful Collaborative Effort
Setting: VA health system with 238 beds across two academic medical centers
Objective
This multidisciplinary clinical improvement initiative compares patient outcomes before and after implementation of nurse-driven standardized intravenous insulin protocol in the ICU, supported by a dose calculator software application (EndoTool).
Setting
VA health system with 238 beds across two academic medical centers.
Results
- Average blood glucose decreased from 137 to 127 mg/dL with EndoTool.
- Average blood glucose 4 hours after insulin initiation decreased from 182 to 126 mg/dL with EndoTool.
- Average peak blood glucose decreased from 255 to 219 mg/dL with EndoTool.
Conclusions
A nurse-driven standardized intravenous insulin protocol, supported by a dose calculator software application (EndoTool), improves glucose control and helps achieve tight glucose control in the ICU.
References
Authors
Melinda Davis, RN, MSN, CCRN, CNL.
Source
Presented at American Association of Critical Care Nurses National Teaching Institute Conference. Published in Critical Care Nurse, Volume 28, Issue 2, pe31.
Year
2008
Related posts
Clinical Evidence
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
20 minute read
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields
